AstraZeneca CEO: Trump tariffs 'not material long term'
AstraZeneca (AZN) CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on pharmaceuticals and said a more favorable corporate tax credit could motivate the industry to reshore manufacturing. "We believe the …